Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jason Baxter and Vincenzo Berghella.
Connection Strength

4.696
  1. Berghella V, Buchanan E, Pereira L, Baxter JK. Preconception care. Obstet Gynecol Surv. 2010 Feb; 65(2):119-31.
    View in: PubMed
    Score: 0.443
  2. Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev. 2008; (4):CD006843.
    View in: PubMed
    Score: 0.405
  3. Berghella V, Roman A, Daskalakis C, Ness A, Baxter JK. Gestational age at cervical length measurement and incidence of preterm birth. Obstet Gynecol. 2007 Aug; 110(2 Pt 1):311-7.
    View in: PubMed
    Score: 0.373
  4. Baxter JK, Airoldi J, Berghella V. Short cervical length after history-indicated cerclage: is a reinforcing cerclage beneficial? Am J Obstet Gynecol. 2005 Sep; 193(3 Pt 2):1204-7.
    View in: PubMed
    Score: 0.326
  5. McCurdy RJ, Delgado DJ, Baxter JK, Berghella V. Influence of weight gain on risk for cesarean delivery in obese pregnant women by class of obesity: pregnancy risk assessment monitoring system (PRAMS). J Matern Fetal Neonatal Med. 2020 Aug 06; 1-7.
    View in: PubMed
    Score: 0.230
  6. Tran TL, Jwala S, Terenna C, McGregor A, Das A, Baxter JK, Berghella V. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic high-risk women. J Matern Fetal Neonatal Med. 2019 Jan 07; 1-7.
    View in: PubMed
    Score: 0.206
  7. Felder L, Paternostro A, Quist-Nelson J, Baxter J, Berghella V. Implementation of vaginal cleansing prior to cesarean delivery to decrease endometritis rates. J Matern Fetal Neonatal Med. 2018 Jan 17; 1-6.
    View in: PubMed
    Score: 0.192
  8. Saccone G, Ciardulli A, Baxter JK, Qui├▒ones JN, Diven LC, Pinar B, Maruotti GM, Martinelli P, Berghella V. Discontinuing Oxytocin Infusion in the Active Phase of Labor: A Systematic Review and Meta-analysis. Obstet Gynecol. 2017 Nov; 130(5):1090-1096.
    View in: PubMed
    Score: 0.190
  9. Orzechowski KM, Boelig RC, Baxter JK, Berghella V. A universal transvaginal cervical length screening program for preterm birth prevention. Obstet Gynecol. 2014 Sep; 124(3):520-5.
    View in: PubMed
    Score: 0.152
  10. Orzechowski KM, Boelig R, Nicholas SS, Baxter J, Berghella V. Is universal cervical length screening indicated in women with prior term birth? Am J Obstet Gynecol. 2015 Feb; 212(2):234.e1-5.
    View in: PubMed
    Score: 0.152
  11. Mackeen AD, Khalifeh A, Fleisher J, Vogell A, Han C, Sendecki J, Pettker C, Leiby BE, Baxter JK, Sfakianaki A, Berghella V. Suture compared with staple skin closure after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2014 Jun; 123(6):1169-75.
    View in: PubMed
    Score: 0.150
  12. Pizzi LT, Seligman NS, Baxter JK, Jutkowitz E, Berghella V. Cost and Cost Effectiveness of Vaginal Progesterone Gel in Reducing Preterm Birth: An Economic Analysis of the PREGNANT Trial. Pharmacoeconomics. 2014 May; 32(5):467-78.
    View in: PubMed
    Score: 0.149
  13. Orzechowski KM, Nicholas SS, Baxter JK, Weiner S, Berghella V. Implementation of a universal cervical length screening program for the prevention of preterm birth. Am J Perinatol. 2014 Dec; 31(12):1057-62.
    View in: PubMed
    Score: 0.148
  14. Mackeen AD, Seibel-Seamon J, Muhammad J, Baxter JK, Berghella V. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst Rev. 2014; 2:CD007062.
    View in: PubMed
    Score: 0.147
  15. Mella MT, Mackeen AD, Gache D, Baxter JK, Berghella V. The utility of screening for historical risk factors for preterm birth in women with known second trimester cervical length. J Matern Fetal Neonatal Med. 2013 May; 26(7):710-5.
    View in: PubMed
    Score: 0.136
  16. Mackeen AD, Seibel-Seamon J, Grimes-Dennis J, Baxter JK, Berghella V. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst Rev. 2011; (10):CD007062.
    View in: PubMed
    Score: 0.124
  17. Seligman NS, Almario CV, Hayes EJ, Dysart KC, Berghella V, Baxter JK. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome. J Pediatr. 2010 Sep; 157(3):428-33, 433.e1.
    View in: PubMed
    Score: 0.113
  18. Baxter JK, Berghella V, Rafael T, Baylson A, Moroz L. Discussion: 'the interleukin-10 gene and cervical insufficiency' by Warren et al. Am J Obstet Gynecol. 2009 Oct; 201(4):e1-4.
    View in: PubMed
    Score: 0.108
  19. Almario CV, Seligman NS, Dysart KC, Berghella V, Baxter JK. Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program. Am J Obstet Gynecol. 2009 Sep; 201(3):326.e1-6.
    View in: PubMed
    Score: 0.107
  20. Berghella V, Baxter JK, Hendrix NW. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database Syst Rev. 2009; (3):CD007235.
    View in: PubMed
    Score: 0.107
  21. Berghella V, Baxter JK, Chauhan SP. Evidence-based labor and delivery management. Am J Obstet Gynecol. 2008 Nov; 199(5):445-54.
    View in: PubMed
    Score: 0.102
  22. Almario CV, Ecker T, Moroz LA, Bucovetsky L, Berghella V, Baxter JK. Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. Am J Obstet Gynecol. 2008 May; 198(5):528.e1-5.
    View in: PubMed
    Score: 0.096
  23. Ness A, Bega G, Wood DC, Baxter J, Weiner S, Berghella V. Massive fetal ileal duplication requiring antenatal intervention. J Ultrasound Med. 2006 Jun; 25(6):785-90.
    View in: PubMed
    Score: 0.086
  24. Ness A, Baxter J, Hyslop T, Berghella V. Progesterone for preventing premature birth: practice patterns of board-certified maternal-fetal medicine specialists in the United States. J Reprod Med. 2006 May; 51(5):411-5.
    View in: PubMed
    Score: 0.085
  25. Berghella V, Baxter JK, Chauhan SP. Evidence-based surgery for cesarean delivery. Am J Obstet Gynecol. 2005 Nov; 193(5):1607-17.
    View in: PubMed
    Score: 0.083
  26. Burd JE, Anderson K, Berghella V, Duncan DG, Baxter JK, Quist-Nelson J. Evaluation of an Initiative to Decrease the Use of Oxygen Supplementation for Category II Fetal Heart Rate Tracings. Obstet Gynecol. 2021 Oct 01; 138(4):627-632.
    View in: PubMed
    Score: 0.062
  27. Johanna QN, Gomez J, Felder L, Di Mascio D, Eckler R, Paternostro A, Baxter J, Berghella V, Posencheg M. Stepwise implementation of vaginal cleansing and azithromycin at cesarean: a quality improvement study. J Matern Fetal Neonatal Med. 2021 Feb 01; 1-8.
    View in: PubMed
    Score: 0.059
  28. Torkzaban M, Haddad A, Baxter JK, Berghella V, Gahl WA, Al-Kouatly HB. Maternal ornithine transcarbamylase deficiency, a genetic condition associated with high maternal and neonatal mortality every clinician should know: A systematic review. Am J Med Genet A. 2019 Aug 22.
    View in: PubMed
    Score: 0.054
  29. Anastasio HB, Mardis R, Khalifeh A, Baxter J, Berghella V, Al-Kouatly HB. Time advantage of HemoCue versus traditional complete blood count during cordocentesis. J Matern Fetal Neonatal Med. 2019 Aug 13; 1-5.
    View in: PubMed
    Score: 0.054
  30. Nicholas S, Orzechowski K, Potti S, Baxter J, Berghella V, Weiner S. Early pregnancy failure as a training tool for chorionic villus sampling. Prenat Diagn. 2013 Nov; 33(11):1110-2.
    View in: PubMed
    Score: 0.035
  31. Mateus J, Pereira L, Baxter J, Berghella V, Tolosa J. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions. Am J Perinatol. 2007 Jun; 24(6):381-5.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.